Cognitive Function and Uremic Toxins after Kidney Transplantation: An Exploratory Study

被引:16
作者
te Linde, Elsemieke [1 ]
van Roij, Claudette J. M. [2 ]
Meijers, Bjorn K., I [3 ,4 ,5 ]
De Loor, Henriette [3 ,4 ,5 ]
Kessels, Roy P. C. [2 ,6 ]
Wetzels, Jack F. M. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Nephrol, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, Nijmegen, Netherlands
[3] Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Leuven, Belgium
[4] Lab Nephrol, Leuven, Belgium
[5] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium
[6] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
来源
KIDNEY360 | 2020年 / 1卷 / 12期
关键词
transplantation; biological toxins; cognition; kidney transplantation; P-CRESYL SULFATE; INDOXYL SULFATE; RENAL-TRANSPLANTATION; HEMODIALYSIS-PATIENTS; CEREBROSPINAL-FLUID; DIALYZED PATIENTS; RISK-FACTORS; IMPAIRMENT; BRAIN; DISEASE;
D O I
10.34067/KID.0000272020
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Cognitive functions are altered in patients with CKD. However, it is suggested that cognitive functions improve after kidney transplantation, at least partially. A possible cause for this improvement could be the reduction of uremic retention solutes after transplantation. This study assessed the association between the changes in uremic toxin concentration with the changes in cognitive function in patients after kidney transplantation. Methods Ten recipients of kidney transplants were compared with 18 controls (nine patients on hemodialysis, and nine patients with CKD stage 4 or 5 [eGFR < 30 ml/min per 1.73 m(2)] who were not on dialysis). An extensive neuropsychological assessment, covering the five major cognitive domains (i.e., memory, attention and concentration, information processing speed, abstract reasoning, and executive function), was done before transplantation, at 1 week post-transplant, and 3 months after transplantation. Similarly, assessments of the 18 matched, control patients were performed longitudinally over a period of 3-5 months. Concentrations of 16 uremic retention solutes (indoxyl glucuronide, p-cresyl glucuronide, phenylglucuronide, 3-carboxy-4-methyl-5propyl-2-furanpropanoic acid, indoxyl sulfate, p-cresyl sulfate, hippuric acid, phenyl sulfate, kynurenine, tryptophan, kynurenic acid, tyrosine, indole-3-acetic acid, phenylalanine, trimethylamine N-oxide, and phenylacetylglutamine) were measured in serum samples collected at the time of the neuropsychological assessments. Results A significant improvement in cognitive function was only found in the processing-speed domain, and this was observed in both patients who received a transplant and patients with CKD. No significant differences between patients who received a transplant and the control groups were seen in the other cognitive domains. As expected, the serum concentration of most uremic toxins decreased significantly within 1 week after kidney transplantation. Conclusions There was no significant improvement in cognitive function that could be specifically related to kidney transplantation in the first 3 months after the procedure. These data do not support the notion that uremic toxins exert an immediate effect on cognitive function.
引用
收藏
页码:1398 / 1406
页数:9
相关论文
共 41 条
[1]   A liquid chromatography - tandem mass spectrometry method to measure a selected panel of uremic retention solutes derived from endogenous and colonic microbial metabolism [J].
de Loor, Henriette ;
Poesen, Ruben ;
De Leger, Wout ;
Dehaen, Wim ;
Augustijns, Patrick ;
Evenepoel, Pieter ;
Meijers, Bjorn .
ANALYTICA CHIMICA ACTA, 2016, 936 :149-156
[2]   The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation [J].
de Vries, Laura V. ;
Minovic, Isidor ;
Franssen, Casper F. M. ;
van Faassen, Martijn ;
Sanders, Jan-Stephan F. ;
Berger, Stefan P. ;
Navis, Gerjan ;
Kema, Ido P. ;
Bakker, Stephan J. L. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2017, 313 (02) :F475-F486
[3]   GUANIDINO COMPOUND LEVELS IN BRAIN-REGIONS OF NON-DIALYZED UREMIC PATIENTS [J].
DEDEYN, PP ;
MARESCAU, B ;
DHOOGE, R ;
POSSEMIERS, I ;
NAGLER, J ;
MAHLER, C .
NEUROCHEMISTRY INTERNATIONAL, 1995, 27 (03) :227-237
[4]   GUANIDINO COMPOUNDS IN SERUM AND CEREBROSPINAL-FLUID OF NON-DIALYZED PATIENTS WITH RENAL-INSUFFICIENCY [J].
DEDEYN, PP ;
MARESCAU, B ;
CUYKENS, JJ ;
VANGORP, L ;
LOWENTHAL, A ;
DEPOTTER, WP .
CLINICA CHIMICA ACTA, 1987, 167 (01) :81-88
[5]   Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier [J].
Deguchi, T ;
Isozaki, K ;
Yousuke, K ;
Terasaki, T ;
Otagiri, M .
JOURNAL OF NEUROCHEMISTRY, 2006, 96 (04) :1051-1059
[6]   Plasma and Urinary Amino Acid Metabolomic Profiling in Patients with Different Levels of Kidney Function [J].
Duranton, Flore ;
Lundin, Ulrika ;
Gayrard, Nathalie ;
Mischak, Harald ;
Aparicio, Michel ;
Mourad, Georges ;
Daures, Jean-Pierre ;
Weinberger, Klaus M. ;
Argiles, Angel .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (01) :37-45
[7]   Normal and Pathologic Concentrations of Uremic Toxins [J].
Duranton, Flore ;
Cohen, Gerald ;
De Smet, Rita ;
Rodriguez, Mariano ;
Jankowski, Joachim ;
Vanholder, Raymond ;
Argiles, Angel .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (07) :1258-1270
[8]   Chronic kidney disease, creatinine and cognitive functioning [J].
Elias, Merrill F. ;
Elias, Penelope K. ;
Seliger, Stephen L. ;
Narsipur, Sriram S. ;
Dore, Gregrory A. ;
Robbins, Michael A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (08) :2446-2452
[9]   Chronic Kidney Disease and Cognitive Impairment: A Systematic Review and Meta-Analysis [J].
Etgen, Thorleif ;
Chonchol, Michel ;
Foerstl, Hans ;
Sander, Dirk .
AMERICAN JOURNAL OF NEPHROLOGY, 2012, 35 (05) :474-482
[10]   Cognitive outcome following kidney transplantation [J].
Gelb, Shannon ;
Shapiro, R. Jean ;
Hill, Amanda ;
Thornton, Wendy Loken .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (03) :1032-1038